The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The gene therapy market has witnessed exponential growth in recent years, driven by factors such as rising cancer incidences, strategic investments, and technological advancements.

Current Market Landscape

• The market is set to escalate from $9.66 billion in 2023 to $12.64 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 30.9%.
• Future projections indicate further expansion, reaching $27.77 billion by 2028, with a CAGR of 21.8%.

Rising Cancer Incidences Drive Growth In The Gene Therapy Market

Impact of Cancer Cases

• The surge in cancer cases globally necessitates effective treatment options, propelling the demand for gene therapy.
• Gene therapy emerges as a promising approach for addressing the rising incidence of cancer and other target diseases.

Statistical Insights: American Cancer Society

• Data from the American Cancer Society highlights the staggering number of new cancer diagnoses and related fatalities in the US, underscoring the urgent need for innovative treatments.
• The prevalence of lung, prostate, bowel, and breast cancer underscores the pivotal role of gene therapy in oncology.

View More On The Gene Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Strategic Investments In Gene Therapy Facilities For Market Advantage

Focus on Infrastructure Development

• Major companies prioritize strategic investments in gene therapy facilities to enhance manufacturing capabilities and gain a competitive edge.
• These investments fuel the establishment of innovation hubs and specialized facilities dedicated to gene therapy research and production.

Example: UK-Based Initiatives

• The Medical Research Council (MRC), LifeArc, and the Biotechnology and Biological Sciences Research Council announced significant investments to create a national network of gene therapy innovation hubs.
• These initiatives aim to revolutionize clinical development and transform patient care, especially for individuals with rare genetic diseases.

Novartis Acquires Gyroscope Therapeutics To Advance Gene Therapy For Eye Diseases

Strategic Acquisition

• Novartis AG’s acquisition of Gyroscope Therapeutics Holdings plc reinforces its commitment to advancing gene therapy research and development.
• The addition of GT005 to Novartis’ portfolio expands gene therapy capabilities and introduces ophthalmic innovations for combating blindness.

Impact on Market Dynamics

• Strategic acquisitions, such as Novartis’ acquisition of Gyroscope Therapeutics, bolster market competitiveness and accelerate the pace of gene therapy innovation.
• These strategic moves enhance research capabilities and strengthen the pipeline of gene therapy products.

Market Segmentation and Regional Insights

Segmentation Overview

• The gene therapy market is segmented based on therapy type, vector, application, and end-users, catering to diverse therapeutic needs and research requirements.
• Segments encompass germline and somatic cell therapy, viral and non-viral vectors, and applications in oncology, orphan diseases, and neurological disorders.

Regional Dominance

• North America emerges as the largest region in the gene therapy market, driven by robust research infrastructure and a supportive regulatory landscape.
• Market dynamics in North America set the pace for global gene therapy advancements and innovation.

Conclusion

The gene therapy market represents a frontier of innovation, offering transformative solutions for addressing complex medical challenges. With a focus on expanding treatment options for cancer and other debilitating diseases, stakeholders are poised to leverage strategic investments, acquisitions, and collaborations to drive market growth. As the gene therapy landscape continues to evolve, fueled by technological advancements and research breakthroughs, the future holds promise for revolutionizing patient care and improving health outcomes on a global scale.

Request A Sample Of The Global Gene Therapy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3395&type=smp